1Jiang R, Manson JE, Meigs JB,et al. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women [J]. JAMA, 2004, 291 ( 6 ): 711.
2Iwasaki T, Nakajima A, Yoneda M, et al. Serum ferritin is associated with visceral fat area and subcutaneous fatarea [J]. Diabetes Care, 2005, 28(10):2486.
3Fernandez-Real JM, Penarroja G, Castro A, et al. Blood letting in high-ferritin type 2 diabetea: effects on insulin sensitivity and β-cell function[J]. Diabetes, 2002,51 (4) : 1000.
2Bains K, Kaur J. Food and nutrient intake in relation to cardiovascular disease among rural males of Punjob, Insia[ J]. Asia Pac J Clin Nutr,2004,13 (suppl) :95.
3Jose MF, Abel LB, Wifredo R. Cross-talk between iron metabolism and diabetes[J]. Diabetes,2002,51 (8) :2 348 -2 354.
4Fernandez-Real JM, Ricart-Engel W, Arroyo E, et al. Serum ferritin as a component of the insulin resistance syndrome [ J ]. Diabetes Care, 1998,21 ( 1 ) :62 -68.
5Jiang R, Manson JE, Meigs JB,et al. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women [ J ]. JAMA, 2004,291 (6) :711 -717.
6Fernandez-Real JM, Penarroja G, Castro A, et al. Blood letting in high-ferritin type 2 diabetes effects on insulin sensitivity and β-cell function[ J]. Diabetes ,2002,51 (4) : 1 000 - 1 004.
7Cutler P. Deferoxamine therapy in high-ferrltin diabetes [ J ]. Diabetes,1989,38(10) :1 207.
6Van Campenhout A,Van Campenhout C,Lagrou AR,et al.Iron-binding antioxidant capacity is impaired in diabetes mellitus[J].Free Radic Biol Med,2006,40(10):1749-1755.
7Fernández-Real JM,Pearroja G,Castro A,et al.Blood letting in high-ferritin type 2 diabetes:effects on insulin sensitivity and β-cell function[J].Diabetes,2002,51(4):1000-1004.
8Eaton JW,Qian M.Molecular bases of cellular iron toxicity[J].Free Radic Biol Med,2002,32(6):833-840.
9Jiang R,Manson JE,Meigs JB,et al.Body iron stores in relation to risk of type 2 diabetes in apparently healthy women[J].JAMA,2004,291(6):711-717.
10Ren Y,Tian HM,Li XJ,et al.Elevated serum ferritin concentrations in a glucose-impaired population and in normal glucose tolerant first-degree relatives in familial type 2 diabetic pedigrees[J].Diabetes Care,2004,27(2):622-623.
